GBI Research, Dec 2011, Pages: 76
landscape, including the benchmarking of topcompanies. Finally, key trends analysis on mergers and acquisitions, and licensing agreements involving pharmaceutical packaging is detailed.
This report
GBI Research, Dec 2010, Pages: 198
diseases including HIV, and autoimmune disorders. A strong product pipeline for most of the top 10 biotechnologycompanies will result in a continuation of this growth trend in the future.
The Highly
Plimsoll Publishing Ltd., May 2012, Pages: 500
Top 450 Biotechnology (Pharmaceuticals) Report (Global) The Global Biotechnology Report
This report is an in-depth financial evaluation of the Global Biotechnology Industry. Using the unique
GBI Research, Dec 2009, Pages: 62
of the competitive landscape, including the benchmarking of topcompanies, key trends on mergers and acquisitions, and licensing agreements involving pharmaceutical packaging.
Global Pharmaceutical Packaging Industry
Global Industry Analysts, Inc., April 2011, Pages: 402
Company 83
Monsanto India to Sell Butachlor & Alachlor Businesses to
Sinochem International 84
Biocon Signs Strategic Partnership Agreement with IATRICa 84
Intas Pharmaceuticals to Sell Biotechnology
Research Facts Ltd, Nov 2010, Pages: 72
Usage: competitive/financial analysis and strategic partner/alliance identification.
2) Suppliers To Molecular Diagnostics Companies
The Top 30 Developers of Molecular Diagnostic Tests For Breast Cancer
GBI Research, Sep 2011, Pages: 114
Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets “Top 20
Business Insights, March 2008, Pages: 280
Pharmaceuticals, Inc. recorded the greatest sales gains over 2002-2006, with an increase of $497.4mn during this period.
- The top 10 fastest growing biotechnologycompanies had a combined R&D expenditure of $734
JZMed Inc., Oct 2011, Pages: 215
professionals of both drug companies and outsourcing service providers as well as financial investment firms the clear insights of the latest development trends in the global pharmaceutical, biotechnology
JZMed Inc., April 2012, Pages: 218
pharmaceutical, biotechnology, financial investment and outsourcing service companies that are interested in having a best position in either one of these two countries. It is also a valuable reference book
Plimsoll Publishing Ltd., May 2012, Pages: 250
BIOTECHNOLOGY AG
VIACELL, INC.
SCICLONE PHARMACEUTICALS INC
MEDAREX INC
INTEGRATED BIOPHARMA INC.
HUMAN GENOME SCIENCES, INC.
DYAX CORP
SHANGHAI RAAS BLOOD PRODUCTS COMPANY LIMITED
ONCOTHYREON INC.
DYNAVAX
Business Insights, Aug 2002
licensing trends, 1997—2000 58
Figure 2.12: Licensing revenues earned by leading 100 biotechnologycompanies, 1997—2001 60
Figure 2.13: Average licensing payments made by top 20 pharmaceuticalcompanies, 1988
Informa Healthcare, Jan 2007, Pages: 118
that is updated to provide tables of ranking on the most important financial criteria used to evaluate company performance. Detailing the financialresults for almost 200 companies in both the pharmaceutical
Moreover Technologies, May 2012 Top 10 Biotech Companies: Media Monitor Companies monitored:
Amgen
Genentech
UCB
Gilead Sciences
Genzyme
Biogen Idec
CSL
Cephalon
Celgene
Actelion
About the service:
When biotechnologycompany
Espicom Business Intelligence Ltd, Nov 2010, Pages: 228
to nine. Pharmaceuticalcompany intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial
Moreover Technologies, May 2012 Top 10 PharmaceuticalCompanies: Media Monitor Companies monitored:
Pfizer
GlaxoSmithKline
Novartis
Sanofi-Aventis
AstraZeneca
Hoffmann–La Roche
Johnson & Johnson
Merck & Co.
Abbott
Eli Lilly
IMS Health, Feb 2009, Pages: 150
- 90+ full in-depth company profiles covering all major pharmaceuticalcompanies worldwide including private companies
- Includes some Generic, Biotechnology and Drug Delivery companies
- Includes sales
